Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 34,394 | 23,593 | 13,774 | 11,440 | 2,180 |
| Depreciation Amortization | 5,204 | 2,413 | 1,825 | 1,050 | 680 |
| Income taxes - deferred | 1,742 | 1,349 | 365 | 0 | 0 |
| Accounts receivable | -1,955 | -3,643 | -1,511 | 0 | 0 |
| Other Working Capital | -7,549 | -26 | -6,456 | -1,530 | -1,310 |
| Other Operating Activity | 1,077 | 2,859 | 5,064 | 250 | 90 |
| Operating Cash Flow | $32,913 | $26,545 | $13,061 | $11,210 | $1,640 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,000 | -1,000 | 0 | 0 |
| PPE Investments | -21,377 | -16,539 | -2,748 | -11,400 | -860 |
| Net Acquisitions | -33,800 | -869 | N/A | 0 | 0 |
| Purchase Of Investment | -61,358 | -7,145 | -55,662 | 0 | 0 |
| Sale Of Investment | N/A | 92 | 21,183 | 0 | 0 |
| Other Investing Activity | 0 | 0 | -16,000 | -260 | -200 |
| Investing Cash Flow | $-116,535 | $-23,461 | $-54,227 | $-11,660 | $-1,060 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,700 | 125 | 500 | 0 | 0 |
| Debt Repayment | -329 | -838 | -15,181 | 0 | 0 |
| Common Stock Issued | 1,123 | 119,454 | 53,200 | 0 | 0 |
| Common Stock Repurchased | -451 | N/A | N/A | 0 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 3,130 | -580 |
| Financing Cash Flow | $6,043 | $118,741 | $38,519 | $3,130 | $-580 |
| Beginning Cash Position | 124,498 | 2,673 | 5,320 | 1,260 | 1,250 |
| End Cash Position | 46,919 | 124,498 | 2,673 | 3,950 | 1,260 |
| Net Cash Flow | $-77,579 | $121,825 | $-2,647 | $2,690 | $2 |
| Free Cash Flow | |||||
| Operating Cash Flow | 32,913 | 26,545 | 13,061 | 11,210 | 1,640 |
| Capital Expenditure | -21,155 | -16,525 | -2,721 | 0 | 0 |
| Free Cash Flow | 11,758 | 10,020 | 10,340 | 11,210 | 1,640 |